ArticleFrontiers in medicine2025
Respiratory rate as a X-ray-based biomarker for the longitudinal assessment of lung function and pathology.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Respiratory rate (RR) is a valuable, yet underexploited lung functional parameter in preclinical lung research, aiding drug toxicity studies, lung disease assessments, stress, pain, and sleep research. It may also enhance translatability between animal and human studies. Longitudinal micro-computed tomography (microCT) lung data acquisitions not only contain spatial information on lung disease, volumes and patterns, but also temporal information covering many breathing cycles. This enables reliable and non-invasive extraction of lung morphological and functional biomarkers, including RR, with a single measurement from free-breathing animals, crucial for accurate measurements. Here, we aimed to develop a non-invasive pipeline, for longitudinal RR monitoring as a biomarker for lung function and pathology based on the X-ray projections of lung microCT acquisitions. First, we mechanically ventilated a mouse and scanned it using microCT at different breathing rates, 60 to 185 breaths per minute (bpm), serving as ground-truth data for our RR measurements. Next, we obtained raw intensity curves from these ground-truth X-ray projections, which contained noise and signals from multiple sources such as respiratory and cardiac cycles. To find the optimal algorithm and isolate the respiratory signals, we post-processed these raw intensity curves with different signal processing techniques. Adept at handling non-uniformly sampled signals in time domain, the Lomb-Scargle (LS) algorithm outperformed the other signal processing techniques, exhibiting robust prediction of RR with an error margin of 3%. Next, we applied this pipeline to benchmark the longitudinal RR data as a biomarker of lung damage and repair in a mouse model of lung epithelial injury. Our RR monitoring pipeline detected a transient loss of lung function in diseased mice, marked by a temporary RR decrease and a simultaneous increase in total lung and aerated lung volumes. Adopting this X-ray-based pipeline would allow lung researchers to non-invasively collect both morphological and functional data in a single measurement, improving insights into lung disease progression and host response thereto by providing relevant biomarkers. This approach contributes to facilitating translation of preclinical study results toward clinical trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.